发明名称 |
Use of rapamycin derivatives in vasculopathies |
摘要 |
<p>Use of 40-O-(2-hydroxy)ethyl-rapamycin, optionally in combination with cyclosporin A, FK-506, azathioprine, methotrexate; mycophenolic acid; mycophenolate mofetil; 15-deoxyspergualine, CTLA4-Ig, or monoclonal antibodies to leukocyte receptors or their ligands; for preventing or treating neointimal proliferation and thickening, e.g. including graft vessel disease and restenosis and/or vascular occlusion following vascular injury.</p> |
申请公布号 |
EP2008657(A3) |
申请公布日期 |
2009.02.04 |
申请号 |
EP20080017336 |
申请日期 |
1997.03.26 |
申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH |
发明人 |
SCHULER, WALTER;SCHUURMANN HESSEL, JOHANNES;WECKBECKER, GISBERT;ZERWES, HANS-GUENTER |
分类号 |
A61K31/436;C07D498/18;A61K31/00;A61K31/435;A61K31/4353;A61P9/00;A61P37/00;A61P37/06;A61P43/00 |
主分类号 |
A61K31/436 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|